The impact of aripiprazole on neurocognitive function in individuals at clinical high risk for psychosis: A comparison with olanzapine and non-antipsychotic treatment

These findings suggest potential associations between antipsychotic use and cognitive outcomes in CHR populations while recognizing that observed differences may reflect baseline illness severity rather than medication effects alone. Aripiprazole may offer specific advantages over olanzapine, underscoring the importance of individualized risk-benefit evaluations in treatment planning. Randomized controlled trials are needed to establish causality.

Authors

Institutions

Publication Details

Journal
European Psychiatry
Published
2025-01-01
DOI
https://doi.org/10.1192/j.eurpsy.2025.2459
Citations
2
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
2.79

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The impact of aripiprazole on neurocognitive function in individuals at clinical high risk for psychosis: A comparison with olanzapine and non-antipsychotic treatment

YuQing Gao, HaiChun Liu, Jijun Wang, JiaYi Ye et al.
2 citations
European Psychiatry
Treatment of Major Depression
2.79
article

The impact of aripiprazole on neurocognitive function in individuals at clinical high risk for psychosis: A comparison with olanzapine and non-antipsychotic treatment

YuQing Gao, HaiChun Liu, Jijun Wang, JiaYi Ye, Tao Chen, HuiRu Cui, XiaoChen Tang, Andrea Raballo, Lihua Xu, Chunbo Li, Liu Xiao-hua, Dan Zhang, Tianhong Zhang, Yingying Tang, YeGang Hu, YanYan Wei, Wenjun Su, Jianzhong Zeng
article en
2 citations

Abstract

These findings suggest potential associations between antipsychotic use and cognitive outcomes in CHR populations while recognizing that observed differences may reflect baseline illness severity rather than medication effects alone. Aripiprazole may offer specific advantages over olanzapine, underscoring the importance of individualized risk-benefit evaluations in treatment planning. Randomized controlled trials are needed to establish causality.

European PsychiatryVol. 68(1)
University of Waterloo (CA), Shanghai Jiao Tong University (CN), Harvard University Press (US), Shanghai Mental Health Center (CN), Center for Excellence in Brain Science and Intelligence Technology (CN), Organizzazione Sociopsichiatrica Cantonale (CH), Institute of Psychology, Chinese Academy of Sciences (CN), Università della Svizzera italiana (CH), Academia Sinica (TW)
Shanghai Municipal Health Commission, National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 11%
Treatment of Major Depression
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.